| pubmed-article:9396067 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9396067 | lifeskim:mentions | umls-concept:C0042373 | lld:lifeskim |
| pubmed-article:9396067 | lifeskim:mentions | umls-concept:C0079281 | lld:lifeskim |
| pubmed-article:9396067 | lifeskim:mentions | umls-concept:C1179435 | lld:lifeskim |
| pubmed-article:9396067 | lifeskim:mentions | umls-concept:C0683481 | lld:lifeskim |
| pubmed-article:9396067 | lifeskim:mentions | umls-concept:C1705248 | lld:lifeskim |
| pubmed-article:9396067 | lifeskim:mentions | umls-concept:C1548799 | lld:lifeskim |
| pubmed-article:9396067 | lifeskim:mentions | umls-concept:C1524073 | lld:lifeskim |
| pubmed-article:9396067 | lifeskim:mentions | umls-concept:C0449432 | lld:lifeskim |
| pubmed-article:9396067 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:9396067 | pubmed:dateCreated | 1998-1-30 | lld:pubmed |
| pubmed-article:9396067 | pubmed:abstractText | Plasma ET-1 was measured around the clock on different calendar dates in healthy subjects and in subjects with diabetes and/or with high blood pressure and/or a history of vascular complications (HVDR). A transverse approach, with each subject contributing a single 24-h mean, assessed any about-weekly or half-weekly variation in ET-1. A circasemiseptan component resolved by single cosinor for nondiabetic (but not for diabetic) HVDR subjects (p = 0.010) differs in its timing of overall high values (p < 0.050) from that found in healthy subjects (p = 0.006). The results are aligned with circasemiseptan patterns in other circulatory variables and morbidity/mortality statistics. | lld:pubmed |
| pubmed-article:9396067 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9396067 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9396067 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9396067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9396067 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9396067 | pubmed:issn | 0196-9781 | lld:pubmed |
| pubmed-article:9396067 | pubmed:author | pubmed-author:HalbergFF | lld:pubmed |
| pubmed-article:9396067 | pubmed:author | pubmed-author:TarquiniBB | lld:pubmed |
| pubmed-article:9396067 | pubmed:author | pubmed-author:CornélissenGG | lld:pubmed |
| pubmed-article:9396067 | pubmed:author | pubmed-author:PerfettoFF | lld:pubmed |
| pubmed-article:9396067 | pubmed:author | pubmed-author:TarquiniRR | lld:pubmed |
| pubmed-article:9396067 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9396067 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:9396067 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9396067 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9396067 | pubmed:pagination | 1237-41 | lld:pubmed |
| pubmed-article:9396067 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:meshHeading | pubmed-meshheading:9396067-... | lld:pubmed |
| pubmed-article:9396067 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9396067 | pubmed:articleTitle | About-half-weekly (circasemiseptan) component of the endothelin-1 (ET-1) chronome and vascular disease risk. | lld:pubmed |
| pubmed-article:9396067 | pubmed:affiliation | University of Minnesota, Department of Laboratory Medicine and Pathology, Lyon Laboratories, Minneapolis 55455, USA. | lld:pubmed |
| pubmed-article:9396067 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9396067 | pubmed:publicationType | Comparative Study | lld:pubmed |
